AB016. Phase 2 clinical trial of PT-112 in patients with thymic epithelial tumors is a research paper published in Mediastinum (2023). On theSindex it has a DataRank of 0. It has been cited 3 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
the Intramural Research Program of the Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health, and via a Cooperative Research and Development Agreement (CRADA) between the NCI and Promontory Therapeutics Inc.
FWCI
0.47
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals